NasdaqGS:TWSTBiotechs
Assessing Twist Bioscience (TWST) Valuation After Preliminary Q1 Revenue Update
Preliminary Q1 Revenue Update Puts Twist Bioscience in Focus
Twist Bioscience (TWST) drew investor attention after announcing preliminary, unaudited revenue for its first fiscal quarter ended December 31, 2025, ahead of full results scheduled for release on February 2, 2026.
See our latest analysis for Twist Bioscience.
The preliminary Q1 revenue update lands after a strong recent run in the stock, with a 30 day share price return of 28.84% and a 90 day share price return of 30.18%. However,...